Wire
Akso Health Commences Proprietary Brain-Computer Interface R&D Program
Akso Health Group (AHG) said Monday it has commenced its proprietary Brain-Computer Interface technology research and development program.It is developing innovations in ultra-high-resolution neural sensing, real-time artificial intelligence neural decoding, and next-generation interface design, with patent applications pending, the company said.The company plans to engineer its BCI program to address unmet needs in neuroscience, advanced therapeutics, and human-machine interaction, according to a statement.Shares of Akso Health Group rose more than 8% in Monday trading.Price: $2.25, Change: $+0.22, Percent Change: +10.57%
$AHG
